Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG’s receptor ILT2 on peripheral CD8(+) T cells

BACKGROUND AND OBJECTIVE: Recurrence of non-muscle invasive bladder cancer (NMIBC) after initial management occurs in 60–70% of patients. Predictive criteria for recurrence remain only clinical and pathological. The aim of this study was to investigate the prognostic significance of the proportion o...

Descripción completa

Detalles Bibliográficos
Autores principales: Desgrandchamps, Francois, LeMaoult, Joel, Goujon, Annabelle, Riviere, Adrien, Rivero-Juarez, Antonio, Djouadou, Malika, de Gouvello, Amory, Dumont, Clement, Wu, Ching-Lien, Culine, Stephane, Verine, Jerome, Rouas-Freiss, Nathalie, Hennequin, Christophe, Masson-Lecomte, Alexandra, Carosella, Edgardo D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145700/
https://www.ncbi.nlm.nih.gov/pubmed/30237859
http://dx.doi.org/10.18632/oncotarget.26036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145700/
https://www.ncbi.nlm.nih.gov/pubmed/30237859
http://dx.doi.org/10.18632/oncotarget.26036

Ejemplares similares